<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  
  
  <title>The anticipated results | Hexo</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <meta name="description" content="This is also the follow-up of the ICI(immune check-point inhibitor) , which is a overall thinking of the  combination treatments with drugs to reduce side effect.   Negative control (no treatment):  K">
<meta property="og:type" content="article">
<meta property="og:title" content="The anticipated results">
<meta property="og:url" content="http://example.com/2021/09/08/results/index.html">
<meta property="og:site_name" content="Hexo">
<meta property="og:description" content="This is also the follow-up of the ICI(immune check-point inhibitor) , which is a overall thinking of the  combination treatments with drugs to reduce side effect.   Negative control (no treatment):  K">
<meta property="og:locale" content="en_US">
<meta property="og:image" content="file:///C:/Users/24180/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif">
<meta property="og:image" content="file:///C:/Users/24180/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif">
<meta property="og:image" content="file:///C:/Users/24180/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif">
<meta property="article:published_time" content="2021-09-08T07:08:09.000Z">
<meta property="article:modified_time" content="2021-09-08T07:19:59.457Z">
<meta property="article:author" content="John Doe">
<meta property="article:tag" content="WORK">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="file:///C:/Users/24180/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif">
  
    <link rel="alternate" href="/atom.xml" title="Hexo" type="application/atom+xml">
  
  
    <link rel="shortcut icon" href="/favicon.png">
  
  
    
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/typeface-source-code-pro@0.0.71/index.min.css">

  
  
<link rel="stylesheet" href="/css/style.css">

  
    
<link rel="stylesheet" href="/fancybox/jquery.fancybox.min.css">

  
<meta name="generator" content="Hexo 5.3.0"></head>

<body>
  <div id="container">
    <div id="wrap">
      <header id="header">
  <div id="banner"></div>
  <div id="header-outer" class="outer">
    <div id="header-title" class="inner">
      <h1 id="logo-wrap">
        <a href="/" id="logo">Hexo</a>
      </h1>
      
    </div>
    <div id="header-inner" class="inner">
      <nav id="main-nav">
        <a id="main-nav-toggle" class="nav-icon"></a>
        
          <a class="main-nav-link" href="/">Home</a>
        
          <a class="main-nav-link" href="/archives">Archives</a>
        
      </nav>
      <nav id="sub-nav">
        
          <a id="nav-rss-link" class="nav-icon" href="/atom.xml" title="RSS Feed"></a>
        
        <a id="nav-search-btn" class="nav-icon" title="Search"></a>
      </nav>
      <div id="search-form-wrap">
        <form action="//google.com/search" method="get" accept-charset="UTF-8" class="search-form"><input type="search" name="q" class="search-form-input" placeholder="Search"><button type="submit" class="search-form-submit">&#xF002;</button><input type="hidden" name="sitesearch" value="http://example.com"></form>
      </div>
    </div>
  </div>
</header>

      <div class="outer">
        <section id="main"><article id="the-results" class="h-entry article article-type-the" itemprop="blogPost" itemscope itemtype="https://schema.org/BlogPosting">
  <div class="article-meta">
    <a href="/2021/09/08/results/" class="article-date">
  <time class="dt-published" datetime="2021-09-08T07:08:09.000Z" itemprop="datePublished">2021-09-08</time>
</a>
    
  </div>
  <div class="article-inner">
    
    
      <header class="article-header">
        
  
    <h1 class="p-name article-title" itemprop="headline name">
      The anticipated results
    </h1>
  

      </header>
    
    <div class="e-content article-entry" itemprop="articleBody">
      
        <p>This is also the follow-up of the ICI(immune check-point inhibitor) , which is a overall thinking of the </p>
<p>combination treatments with drugs to reduce side effect.  </p>
<p><strong>Negative control (no treatment):</strong> </p>
<p><strong>KM-curve:</strong> Poorest curve that has the steepest slope( which means many mice dead in a short amount of time). </p>
<p><strong>Tumor size and density:</strong> Largest average tumor size and most tumors presented</p>
<p><strong>Immunologic</strong>: Least number of lymphocytes and myeloid cells. </p>
<p><strong>T cell activation</strong>: Least amount of fluorescence (least amount of activated T cell against tumor cell)</p>
<p><strong>ICI (PD-1) only:</strong></p>
<p><strong>KM-curve:</strong> A better curve that has the flatter slope</p>
<p><strong>Tumor size and density:</strong> smaller average tumor size and reduced number of tumors presented</p>
<p><strong>Immunologic</strong>: More lymphocytes and myeloid cells were presented. </p>
<p><strong>T cell activation</strong>: Increased amount of fluorescence </p>
<p><strong>ICI with MAPK (RAS inhibitor):</strong></p>
<p><strong>KM-curve:</strong> A better curve that has a flatter slope than ICI only</p>
<p><strong>Tumor size and density:</strong> smaller average tumor size and reduced number of tumors presented compared to ICI only</p>
<p><strong>Immunologic</strong>: More lymphocytes and myeloid cells were presented. </p>
<p><strong>T cell activation</strong>: Increased amount of fluorescence </p>
<p><strong>ICI with the oncolytic virus (T-vec):</strong></p>
<p>similar to ICI with MAPK</p>
<p><strong>Triple combination (ICI + T-vec + kinase inhibitors):</strong> </p>
<p><strong>KM-curve:</strong> The best curve (except positive control) that has the flattest curve</p>
<p><strong>Tumor size and density:</strong> smallest average tumor size and least number of tumors presented compared to ICI only</p>
<p><strong>Immunologic</strong>: Most lymphocytes and myeloid cells were presented. </p>
<p><strong>T cell activation</strong>: Maximum amount of fluorescence </p>
<p><strong>Positive control (no tumor): normal lifespan without injection</strong></p>
<p><strong>KM-curve:</strong> The curve shows the natural rate of death</p>
<p><strong>Tumor size and density:</strong> shouldn’t present except spontaneous mutation</p>
<p><strong>Immunologic</strong>: Normal lymphocytes and myeloid cells were presented. </p>
<p><strong>T cell activation</strong>: Only few fluorescence (No pathogen, so no requirement to get activated) </p>
<p><img src="file:///C:/Users/24180/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" alt="Chart, line chart  Description automatically generated"></p>
<p><em>Graph 1.</em> The survival curve of each experimental group</p>
<p><img src="file:///C:/Users/24180/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" alt="Chart, line chart  Description automatically generated"></p>
<p><em>Graph 2.</em> The average tumor size of each experimental group. ICI treatment can initially increase tumor size.</p>
<p><em>Graph 3.</em> Fluorscence intensity of each experimental group (will be added later, require minor edit)</p>
<hr>
<p> Precondition: In the ideal state, the same number of the humanized mice in the four groups have both symptoms cause by ICIs.</p>
<p>*DCR (*disease control rate) </p>
<p>Explanation: 1 represents be controlled totally</p>
<p>​      0 represents not be controlled</p>
<p>OSR (<strong>overall survival rate</strong>)</p>
<p><strong>negative control:</strong></p>
<p><strong>DCR-curve</strong> <strong>not be controlled</strong></p>
<p><strong>OS-curve:</strong> Poorest curve that has the steepest slope </p>
<p><strong>irAE related symptoms and biomarkers:</strong> Most severe</p>
<p><strong>inflammation symptoms and cytokine concentration:</strong> Most severe and Highest</p>
<p><strong>triple combination with anti-IL6 antibodies:</strong> </p>
<p><strong>DCR-curve: be partly controlled</strong></p>
<p><strong>OS-curve:</strong> A better curve that has the flatter slope</p>
<p>(note: anti-cytokine antibodies seems to suppress the therapeutic effect of triple combination)</p>
<p><strong>irAE related symptoms and biomarkers:</strong> Less severe</p>
<p><strong>inflammation symptoms and cytokine concentration:</strong> Less severe and Lower</p>
<p><strong>triple combination with corticosteroid:</strong> </p>
<p><strong>DCR-curve: be partly controlled</strong></p>
<p><strong>OS-curve:</strong> A better curve that has the flatter slope</p>
<p><strong>irAE related symptoms and biomarkers:</strong> Less severe (a bit more severe than anti-IL6 antibodies)</p>
<p><strong>inflammation symptoms and cytokine concentration:</strong> Less severe and Lower (more reduced effect than anti-IL6 antibodies)</p>
<p><strong>triple combination with both side effect reducing drug:</strong></p>
<p><strong>DCR-curve: be well controlled</strong></p>
<p><strong>OS-curve:</strong> A better curve that has the flatter slope</p>
<p><strong>irAE related symptoms and biomarkers:</strong> Least severe (except positive control)</p>
<p><strong>inflammation symptoms and cytokine concentration:</strong> Least severe, and lowest cytokine concentration. </p>
<p><strong>positive control:</strong></p>
<p><strong>DCR-curve: do not need to control</strong></p>
<p><strong>OS-curve: normal life and death rate</strong></p>
<p><img src="file:///C:/Users/24180/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" alt="Chart, line chart  Description automatically generated"></p>
<p><em>Graph 4.</em> The OS curve of experimental groups</p>

      
    </div>
    <footer class="article-footer">
      <a data-url="http://example.com/2021/09/08/results/" data-id="cktzgi4pf000zxgtec0zjg01y" data-title="The anticipated results" class="article-share-link">Share</a>
      
      
      
  <ul class="article-tag-list" itemprop="keywords"><li class="article-tag-list-item"><a class="article-tag-list-link" href="/tags/WORK/" rel="tag">WORK</a></li></ul>

    </footer>
  </div>
  
    
<nav id="article-nav">
  
    <a href="/2021/09/08/IM/" id="article-nav-newer" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Newer</strong>
      <div class="article-nav-title">
        
          IM
        
      </div>
    </a>
  
  
    <a href="/2021/02/25/The-Experiment3/" id="article-nav-older" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Older</strong>
      <div class="article-nav-title">The Experiment3</div>
    </a>
  
</nav>

  
</article>


</section>
        
          <aside id="sidebar">
  
    

  
    
  <div class="widget-wrap">
    <h3 class="widget-title">Tags</h3>
    <div class="widget">
      <ul class="tag-list" itemprop="keywords"><li class="tag-list-item"><a class="tag-list-link" href="/tags/Exercise/" rel="tag">Exercise</a></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Markdown/" rel="tag">Markdown</a></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/WORK/" rel="tag">WORK</a></li></ul>
    </div>
  </div>


  
    
  <div class="widget-wrap">
    <h3 class="widget-title">Tag Cloud</h3>
    <div class="widget tagcloud">
      <a href="/tags/Exercise/" style="font-size: 10px;">Exercise</a> <a href="/tags/Markdown/" style="font-size: 15px;">Markdown</a> <a href="/tags/WORK/" style="font-size: 20px;">WORK</a>
    </div>
  </div>

  
    
  <div class="widget-wrap">
    <h3 class="widget-title">Archives</h3>
    <div class="widget">
      <ul class="archive-list"><li class="archive-list-item"><a class="archive-list-link" href="/archives/2021/09/">September 2021</a></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2021/02/">February 2021</a></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2021/01/">January 2021</a></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2020/11/">November 2020</a></li><li class="archive-list-item"><a class="archive-list-link" href="/archives/2020/10/">October 2020</a></li></ul>
    </div>
  </div>


  
    
  <div class="widget-wrap">
    <h3 class="widget-title">Recent Posts</h3>
    <div class="widget">
      <ul>
        
          <li>
            <a href="/2021/09/25/imgtest/">imgtest</a>
          </li>
        
          <li>
            <a href="/2021/09/08/%E8%AF%BB%E5%90%8E%E6%84%9F/">读后感</a>
          </li>
        
          <li>
            <a href="/2021/09/08/life/">Goals in life</a>
          </li>
        
          <li>
            <a href="/2021/09/08/show/">Notes show</a>
          </li>
        
          <li>
            <a href="/2021/09/08/IM/">IM</a>
          </li>
        
      </ul>
    </div>
  </div>

  
</aside>
        
      </div>
      <footer id="footer">
  
  <div class="outer">
    <div id="footer-info" class="inner">
      
      &copy; 2021 John Doe<br>
      Powered by <a href="https://hexo.io/" target="_blank">Hexo</a>
    </div>
  </div>
</footer>

    </div>
    <nav id="mobile-nav">
  
    <a href="/" class="mobile-nav-link">Home</a>
  
    <a href="/archives" class="mobile-nav-link">Archives</a>
  
</nav>
    


<script src="/js/jquery-3.4.1.min.js"></script>



  
<script src="/fancybox/jquery.fancybox.min.js"></script>




<script src="/js/script.js"></script>





  </div>
</body>
</html>